Ethical Considerations
NCT05306015
This study was conducted at the cardiac catheterization laboratory of the First Affiliated Hospital of Nanjing Medical University, Nanjing, China, from April to September 2022. All study patients provided oral or written informed consent. This study was approved by the ethics committee of the First Affiliated Hospital of Nanjing Medical University (2022-SR-086) and registered at ClinicalTrials.gov (NCT05306015). Procedures were conducted in accordance with the tenets of the Declaration of Helsinki.